Clarivate to sell Life Sciences & Healthcare unit to Altaris for $600 million

The company said the divestiture will sharpen its focus on Academia & Government and Intellectual Property, cut debt and support its full-year 2026 outlook, with the deal expected to close by year-end.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.